What is medetomidine and why is it causing a crisis in Philadelphia?

Medetomidine is a powerful veterinary sedative, not intended for human use, that has entered Philadelphia's drug supply. It causes severe withdrawal symptoms that are overwhelming hospitals.

How has medetomidine impacted Philadelphia hospitals?

Hospitals in Philadelphia have been strained by a surge in patients experiencing medetomidine withdrawal, leading to ICU overcrowding and an increase in critical care needs.

What are the withdrawal symptoms of medetomidine?

Withdrawal from medetomidine can cause catastrophically high heart rates and blood pressure, tremors, uncontrollable vomiting, and in severe cases, require intensive care.

Home / Health / Veterinary Sedative Fuels New Opioid Epidemic Nightmare

Veterinary Sedative Fuels New Opioid Epidemic Nightmare

15 Dec

•

Summary

Medetomidine, a vet sedative, causes severe withdrawal, overwhelming hospitals.
Drug supply in Philadelphia sees 91% fentanyl mix with medetomidine.
Hospital admissions for withdrawal surged over 160% in nine months.

Veterinary Sedative Fuels New Opioid Epidemic Nightmare

Philadelphia is grappling with a new drug crisis fueled by medetomidine, a potent veterinary sedative. This drug, now found in 91% of the city's fentanyl supply, causes severe and life-threatening withdrawal symptoms, including dangerously high blood pressure and heart rates, overwhelming local hospitals.

The consequences are dire, with hospital admissions for medetomidine withdrawal soaring by over 160% in the first nine months of 2025 compared to all of 2023. This situation strains emergency services and has led to intensive care units being overburdened, creating a distinct "withdrawal crisis."

Medetomidine's addictive nature and low cost make it attractive to drug dealers, and its impact is spreading to other states. The crisis highlights the evolving challenges of addiction, with withdrawal, not overdose, becoming the primary threat.